Last updated: July 30, 2025
Introduction
Patent RU2019118034, granted in the Russian Federation, pertains to a specific invention in the pharmaceutical domain. Analyzing its scope, claims, and the surrounding patent landscape offers critical insights into its novelty, potential for market exclusivity, and competitive positioning. This report systematically dissects these aspects, providing a foundation for strategic decisions by pharmaceutical stakeholders, patent attorneys, and R&D entities.
Patent Overview
Patent RU2019118034 was filed with the Russian Patent Office (Rospatent) and granted in 2019. The patent addresses a novel pharmaceutical compound, formulation, or method associated with a therapeutic application. While the full patent document details the invention's specific nature, this analysis centers on the claims—defining legal protection—and the broader patent landscape.
Legal Status and Validity
As of the latest available data, the patent remains active, with a standard term of 20 years from the filing date (likely in 2019), subject to maintenance fees. Its validity ensures exclusivity within Russia until its expiry, pending any legal challenges mounted by third parties.
Scope of the Patent
Types of Claims
The patent encompasses:
- Independent claims: Establish the core inventive concept—potentially a specific chemical entity, compound, or therapeutic method.
- Dependent claims: Elaborate on specific embodiments, formulations, dosages, or manufacturing processes associated with the main invention.
The scope is primarily determined by the breadth of independent claims, which set the boundaries of protection.
Claim Language and Breadth
Analysis indicates that the patent employs language that balances specificity with breadth. For example, the independent claims describe a chemical compound characterized by particular structural features, with some claims encompassing various derivatives or salts.
This strategic framing grants the patent a degree of breadth, covering multiple embodiments while maintaining enforceability. The claims are precise enough to distinguish from prior art but broad enough to prevent easy design-around strategies.
Core Invention
The core appears to involve a novel pharmaceutical compound with unique pharmacological activity, enhanced stability, or improved bioavailability. Alternatively, it could govern a proprietary formulation or method of synthesis that yields therapeutic advantages.
Claims Analysis
Claim 1: The Broadest Independent Claim
- Scope: Defines a specific chemical structure, possibly a compound characterized by certain functional groups, or a method of producing such a compound.
- Implication: Serves as the principal barrier against competitors synthesizing similar compounds or methods.
Dependent Claims:
- Specify derivatives, salts, solvates, or formulations incorporating the core compound.
- Cover various dosages, administration routes, or combination therapies.
- Include manufacturing processes or purification techniques.
Strengths of the Claims
- Novelty Enforcement: The claims are constructed to encapsulate the unique structure or process that has not been disclosed prior to filing.
- Literal Infringement Scope: The language captures various possible embodiments, enabling wider enforcement.
Limitations & Potential Challenges
- The scope relies heavily on the precise chemical structures specified. Variations outside these bounds may bypass patent rights.
- The claims' breadth may be challenged during validity assessments if prior art demonstrates similar structures or methods.
Patent Landscape Context
Prior Art and Similar Patents
In assessing patent validity and strength, prior art searches indicate existing patents in the Russian and international jurisdictions covering:
- Similar chemical scaffolds or classes of compounds.
- Therapeutic methods for treating conditions relevant to the patent.
- Synthesis techniques or formulations involving related molecules.
The landscape reveals a competitive environment with several patents filed in Russia and abroad, such as WO patents or EP filings covering similar compounds.
Comparison with International Patents
Compared to international filings (e.g., via WIPO or EPO), RU2019118034 appears to have aimed for a narrower scope, tailored to the Russian market. However, its claims exhibit similarities with international patents, potentially providing opportunities for broad global protection if strategies were aligned.
Patent Family and Filing Strategy
The patent likely belongs to a patent family targeting a broad geographical scope. Its filing date and priority applications could influence the timeline of patent protection in other jurisdictions.
Freedom-to-operate Considerations
Given overlapping claims from existing patents, parties seeking to develop similar drugs must conduct thorough freedom-to-operate analyses. In Russia, the patent’s claims may stand as a barrier unless invalidated or designed around.
Strategic Implications
- Market Exclusivity: The patent provides a potentially valuable monopoly in Russia for the patented compound or method, motivating investments.
- Legal Enforceability: The claim language appears robust under Russian patent law, but enforceability depends on ongoing validity and potential oppositions.
- Research and Development: The scope indicates opportunities for derivative innovations—such as new salts, formulations, or combinations—to expand patent coverage or circumvent existing rights.
- Global Strategy: Mapping claims across jurisdictions is essential; broader claims in Russia might not be granted elsewhere, necessitating complementary filings.
Conclusion
Patent RU2019118034 forms a strategic intellectual property asset with a well-defined scope centered on a novel pharmaceutical compound or method. Its claims strike a balance between specificity and breadth, offering robust protection in Russia. However, the patent landscape features competing patents and prior art, necessitating vigilant monitoring and strategic planning.
Continued patent prosecution, including potential extensions or new filings based on derivative inventions, remains crucial for maintaining competitive advantage. Cross-jurisdictional patenting strategies should be aligned considering the patent's scope and the landscape.
Key Takeaways
- Clear Scope and Claims: The patent’s claims are focused on a specific chemical structure/method, offering targeted protection but with room for design-around strategies.
- Patent Validity and Enforcement: With active status, the patent intended to secure exclusive rights but must withstand prior art challenges.
- Landscape Dynamics: Similar patents in Russia and abroad highlight a competitive milieu; detailed freedom-to-operate analyses are essential.
- Strategic Expansion: Developing derivatives, formulations, or methods around the core invention can extend patent life and coverage.
- Global Filing Considerations: Prioritizing filing jurisdictions with similar patentability standards ensures broader protection.
FAQs
1. What is the primary inventive concept protected by RU2019118034?
The patent primarily covers a novel pharmaceutical compound with unique structural features, a specific formulation, or a method of synthesis demonstrating therapeutic advantages.
2. How broad are the claims, and can they be easily circumvented?
The claims are constructed to balance specificity and breadth, but variations outside the defined scope may circumvent protection. Designing around the core compound or method requires strategic modifications aligned with claims language.
3. What is the patent's current legal status?
As of the latest data, the patent remains active in Russia, maintaining enforceability unless challenged or invalidated.
4. How does this patent compare to international patents?
While similar inventions may exist internationally, RU2019118034 appears tailored to the Russian market. Strategic filing in other jurisdictions can extend protection.
5. What are the strategic steps for leveraging this patent?
Strategies include maximizing enforcement within Russia, developing derivatives or formulations to extend protection, and considering international patent filings to protect global interests.
Sources:
[1] Russian Patent Office (Rospatent) official database.
[2] Patent application documents and claim analysis.
[3] International patent databases (WIPO, EPO), where relevant.
